These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28449719)

  • 41. Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.
    Andersson AC; Holst PJ
    J Transl Med; 2016 Dec; 14(1):343. PubMed ID: 27998269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
    Sin JI; Kim JJ; Ugen KE; Ciccarelli RB; Higgins TJ; Weiner DB
    Eur J Immunol; 1998 Nov; 28(11):3530-40. PubMed ID: 9842896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
    Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination of mice with ORF5 plasmid DNA of PRRSV; enhanced effects by co-immunizing with porcine IL-15.
    Li G; Shi N; Suo S; Cui J; Zarlenga D; Ren X
    Immunol Invest; 2012; 41(3):231-48. PubMed ID: 22017604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).
    Nihrane A; Silver J
    Immunology; 1997 Feb; 90(2):219-28. PubMed ID: 9135550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
    Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W; Yang ZY; Nabel GJ
    J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens.
    Gherardi MM; Ramírez JC; Esteban M
    Histol Histopathol; 2001 Apr; 16(2):655-67. PubMed ID: 11332721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of cytokine-encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice.
    Bharati K; Appaiahgari MB; Vrati S
    Microbiol Immunol; 2005; 49(4):349-53. PubMed ID: 15840960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kunjin virus replicon vectors for human immunodeficiency virus vaccine development.
    Harvey TJ; Anraku I; Linedale R; Harrich D; Mackenzie J; Suhrbier A; Khromykh AA
    J Virol; 2003 Jul; 77(14):7796-803. PubMed ID: 12829819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.
    Zhang W; Dong SF; Sun SH; Wang Y; Li GD; Qu D
    World J Gastroenterol; 2006 Aug; 12(29):4727-35. PubMed ID: 16937447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of protective immunity to Friend murine leukemia virus in genetic nonresponders to virus envelope protein.
    Ishihara C; Miyazawa M; Nishio J; Chesebro B
    J Immunol; 1991 Jun; 146(11):3958-63. PubMed ID: 2033265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant action of murine IL-2/Ig plasmid after intramuscular immunization with Indian HIV-1 subtype C recombinant env.gp 120 construct.
    Aggarwal P; Kumar S; Vajpayee M; Seth P
    Viral Immunol; 2005; 18(4):649-56. PubMed ID: 16359231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.
    Song R; Liu S; Adams RJ; Leong KW
    J Interferon Cytokine Res; 2006 Jun; 26(6):380-9. PubMed ID: 16734558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants.
    Ohlschläger P; Quetting M; Alvarez G; Dürst M; Gissmann L; Kaufmann AM
    Int J Cancer; 2009 Jul; 125(1):189-98. PubMed ID: 19358269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-free transmission of Fv-4 resistance gene product controlling Friend leukemia virus-induced leukemogenesis: a unique mechanism for interference with viral infection.
    Kitagawa M; Aizawa S; Kamisaku H; Ikeda H; Hirokawa K; Sado T
    Blood; 1995 Aug; 86(4):1557-63. PubMed ID: 7632964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity.
    Sang H; Pisarev VM; Munger C; Robinson S; Chavez J; Hatcher L; Parajuli P; Guo Y; Talmadge JE
    Vaccine; 2003 Jun; 21(21-22):3019-29. PubMed ID: 12798646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
    Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
    BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.
    Otero M; Calarota SA; Felber B; Laddy D; Pavlakis G; Boyer JD; Weiner DB
    Vaccine; 2004 Apr; 22(13-14):1782-90. PubMed ID: 15068862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.